Xifaxan 550 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DR26FM14E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $46,087
Award facts
- Contract value 100% obligated
- $46,087.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Xifaxan 550 mg tablets in quantities of 60 units, with a contract ceiling value of $46,087.40. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The delivery is scheduled for completion by November 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that supports global pharmaceutical supply chains for military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Department of Defense and related federal health systems. The company maintains an extensive portfolio of pharmaceutical products and medical supplies delivered through competitive contract vehicles, demonstrating consistent capability to meet federal procurement standards. This award reflects the company's ongoing role in supporting military healthcare through the DLA's Troop Support Medical supply chain, which encompasses brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. The DLA Troop Support has indicated plans to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple awards across separate regions, positioning AmerisourceBergen among key contractors supporting this strategic initiative.
Quick answers
Who was awarded contract SPE2DR26FM14E?
SPE2DR26FM14E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FM14E worth?
The government has obligated $46,087 on SPE2DR26FM14E.
Is contract SPE2DR26FM14E an order under another contract?
Yes. SPE2DR26FM14E is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM14E competed?
The extent of competition for SPE2DR26FM14E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award